Role of Matrix Metalloproteases in Degradation of ECM
MAPK Signaling Cascades
Acute Kidney Injury II: Pathophysiology
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Non-Canonical Wnt Signaling Pathways
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 8, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Justyna Wozniak1, Jürgen Floege2, Tammo Ostendorf3
1Institute of Molecular Pharmacology, RWTH Aachen University, Aachen, Germany.
Matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinases (ADAMs) are key in kidney disease. Targeting specific MMPs and ADAMs shows promise for treating kidney fibrosis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: